Celldex Therapeutics
CLDX
$37.28
Share price
-1.30%
Change (1 day)
7.34%
Change (1 year)
Categories
Earnings for Celldex Therapeutics (CLDX)
Earnings in 2023 (TTM): -$0.15 B
According to Celldex Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.15 B. a decrease over its 2022 earnings that were of -$0.11 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Celldex Therapeutics from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | -$0.15 B | 32.63% |
| 2022 | -$0.11 B | 54.88% |
| 2021 | -$69.15 M | 39.49% |
| 2020 | -$49.58 M | -9.08% |
| 2019 | -$54.53 M | -28.64% |
| 2018 | -$76.41 M | -30.11% |
| 2017 | -$0.11 B | -17.75% |
| 2016 | -$0.14 B | 4.5% |
| 2015 | -$0.13 B | 4.09% |
| 2014 | -$0.13 B | 51.57% |
| 2013 | -$80.63 M | 40.1% |
| 2012 | -$57.55 M | |
| 2010 | -$1.25 M | -96.59% |
| 2009 | -$36.61 M | |
| 2006 | -$22.37 M | |
| 2004 | -$13.59 M | 15.75% |
| 2003 | -$11.74 M | -18.69% |
| 2002 | -$14.44 M | -41.22% |
| 2001 | -$24.56 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $3.26 B | -2,400.02% | 🇺🇸 USA |
 Amgen AMGN | $7.85 B | -5,630.05% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $7.53 B | -5,404.78% | 🇬🇧 UK |
 Titan Pharmaceuticals
TTNP | -$5.57 M | -96.08% | 🇺🇸 USA |
 Seagen
SGEN | -$0.8 B | 456.58% | 🇺🇸 USA |
 Agenus
AGEN | -$0.16 B | 12.30% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -$0.65 B | 353.25% | 🇺🇸 USA |